EXHIBIT 10.22 [*#*] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED....Exclusive Patent and Technology License Agreement • October 28th, 2003 • Myogen Inc • Pharmaceutical preparations • Texas
EXHIBIT 10.16 EXCLUSIVE PATENT AND TECHNOLOGY LICENSE AGREEMENT THIS EXCLUSIVE PATENT AND TECHNOLOGY LICENSE AGREEMENT, having an effective date of February 1st, 1995, (hereinafter "Effective Date") by and between Schlumberger Technology Corporation...Exclusive Patent and Technology License Agreement • April 5th, 2002 • Cti Inc /Tn • Tennessee
Institutional Conflict of Interest Management and Monitoring Plan: Spectrum Pharmaceuticals, Inc.Exclusive Patent and Technology License Agreement • April 18th, 2019
The University of Texas MD Anderson (MD Anderson) and Spectrum Pharmaceuticals, Inc. (Spectrum) are parties to an Exclusive Patent and Technology License Agreement (Agreement) pursuant to which MD Anderson and (Spectrum) will collaborate on the conduct of at least two Phase II clinical trials and possibly other trials involving MD Anderson’s Licensed Technology.
EXCLUSIVE PATENT AND TECHNOLOGY LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF TEXAS SYSTEMExclusive Patent and Technology License Agreement • March 30th, 2004 • Dor Biopharma Inc • Pharmaceutical preparations • Texas
This Patent and Technology License Agreement (the AGREEMENT) is made between the Board of Regents (BOARD) of the University of Texas System (SYSTEM), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas Southwestern Medical Center at Dallas (UT SOUTHWESTERN), a component institution of SYSTEM, and DOR Vaccines, Inc. (LICENSEE) , an Delaware corporation, with its principal place of business at 28101 Ballard Drive, Lake Forest, Illinois 60045.
